Fig. 1
From: Juvenile Dermatomyositis in Afro-Caribbean children: a cohort study in the French West Indies
Background therapy throughout childhood for Juvenile dermatomyositis. MTX, Methotrexate. Initial treatment of a flare was based on high-dose steroid therapy gradually tapered and weaned over 3–6 months. Corticosteroid-sparing treatment was administered in the event of corticosteroid dependence or relapse